| Literature DB >> 11485735 |
J Liu1, S Na, A Glasebrook, N Fox, P J Solenberg, Q Zhang, H Y Song, D D Yang.
Abstract
We have found that DR6, a member of the TNF receptor family, is highly expressed in resting T cells and downregulated in activated T cells. DR6-targeted mutant mice were generated and showed normal development. However, DR6(-/-) CD4(+) T cells hyperproliferated in response to TCR-mediated stimulation and protein antigen challenge. Activated DR6(-/-) CD4(+) T cells exhibited upregulated CD25 expression and enhanced proliferation in response to exogenous IL-2 stimulation. In addition, increased CD28 and reduced CTLA-4 expression were observed in these cells. Enhanced Th2 cytokine production by activated DR6(-/-) CD4(+) T cells was associated with the increased transcription factor NF-ATc in nuclei. DR6, therefore, functions as a regulatory receptor for mediating CD4(+) T cell activation and maintaining proper immune responses.Entities:
Mesh:
Substances:
Year: 2001 PMID: 11485735 DOI: 10.1016/s1074-7613(01)00162-5
Source DB: PubMed Journal: Immunity ISSN: 1074-7613 Impact factor: 31.745